智通财经网·2026-01-09 11:27Core Viewpoint - The chairman and controlling shareholder of Junshi Biosciences (01877), Mr. Xiong Jun, plans to increase his stake in the company by at least RMB 100 million over the next 12 months starting from April 12, 2025 [1] Summary by Relevant Sections - Shareholding Increase Plan - Mr. Xiong intends to acquire both A-shares and H-shares of the company, with a minimum of RMB 50 million allocated for A-shares [1] - Current Shareholding Activity - As of the announcement date, Mr. Xiong has already purchased 100,000 A-shares through the Shanghai Stock Exchange, representing approximately 0.01% of the company's total share capital, with a total transaction value of RMB 3.8384 million [1] - Future Actions - The share purchase plan is still in progress, and Mr. Xiong will continue to buy shares opportunistically during the implementation period of the plan [1]